ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/29 | 2,483 | 2,483 | 2,441 | 2,451 | -24 | -1% | 66,000 |
2023/05/26 | 2,506 | 2,508 | 2,467 | 2,475 | -40 | -1.6% | 87,300 |
2023/05/25 | 2,498 | 2,527 | 2,485 | 2,515 | ±0 | ±0% | 70,300 |
2023/05/24 | 2,530 | 2,538 | 2,515 | 2,515 | -12 | -0.5% | 41,200 |
2023/05/23 | 2,527 | 2,541 | 2,507 | 2,527 | +3 | +0.1% | 65,800 |
2023/05/22 | 2,514 | 2,535 | 2,502 | 2,524 | +17 | +0.7% | 40,500 |
2023/05/19 | 2,525 | 2,525 | 2,492 | 2,507 | -18 | -0.7% | 78,400 |
2023/05/18 | 2,540 | 2,540 | 2,475 | 2,525 | -9 | -0.4% | 90,500 |
2023/05/17 | 2,535 | 2,547 | 2,512 | 2,534 | -1 | ±0% | 65,100 |
2023/05/16 | 2,530 | 2,535 | 2,504 | 2,535 | +10 | +0.4% | 59,800 |
2023/05/15 | 2,468 | 2,525 | 2,464 | 2,525 | +79 | +3.2% | 159,000 |
2023/05/12 | 2,431 | 2,448 | 2,398 | 2,446 | +32 | +1.3% | 105,800 |
2023/05/11 | 2,435 | 2,466 | 2,404 | 2,414 | -54 | -2.2% | 124,800 |
2023/05/10 | 2,470 | 2,480 | 2,454 | 2,468 | -2 | -0.1% | 89,200 |
2023/05/09 | 2,468 | 2,475 | 2,449 | 2,470 | +2 | +0.1% | 69,700 |
2023/05/08 | 2,454 | 2,478 | 2,451 | 2,468 | -3 | -0.1% | 82,200 |
2023/05/02 | 2,472 | 2,487 | 2,452 | 2,471 | +21 | +0.9% | 95,900 |
2023/05/01 | 2,425 | 2,467 | 2,425 | 2,450 | +20 | +0.8% | 66,400 |
2023/04/28 | 2,415 | 2,430 | 2,404 | 2,430 | +41 | +1.7% | 69,100 |
2023/04/27 | 2,374 | 2,405 | 2,355 | 2,389 | -6 | -0.3% | 85,200 |
2023/04/26 | 2,387 | 2,404 | 2,377 | 2,395 | -16 | -0.7% | 43,800 |
2023/04/25 | 2,415 | 2,453 | 2,407 | 2,411 | +3 | +0.1% | 126,800 |
2023/04/24 | 2,382 | 2,417 | 2,374 | 2,408 | +32 | +1.3% | 114,100 |
2023/04/21 | 2,355 | 2,394 | 2,347 | 2,376 | +25 | +1.1% | 93,300 |
2023/04/20 | 2,339 | 2,370 | 2,339 | 2,351 | +7 | +0.3% | 80,000 |
2023/04/19 | 2,341 | 2,353 | 2,329 | 2,344 | -27 | -1.1% | 93,900 |
2023/04/18 | 2,355 | 2,376 | 2,344 | 2,371 | +16 | +0.7% | 77,200 |
2023/04/17 | 2,382 | 2,382 | 2,354 | 2,355 | -24 | -1% | 86,100 |
2023/04/14 | 2,360 | 2,383 | 2,358 | 2,379 | +32 | +1.4% | 68,500 |
2023/04/13 | 2,323 | 2,353 | 2,318 | 2,347 | +31 | +1.3% | 62,800 |
2023/04/12 | 2,315 | 2,338 | 2,312 | 2,316 | +16 | +0.7% | 54,200 |
2023/04/11 | 2,279 | 2,302 | 2,273 | 2,300 | +27 | +1.2% | 75,300 |
2023/04/10 | 2,270 | 2,278 | 2,257 | 2,273 | +23 | +1% | 35,400 |
2023/04/07 | 2,260 | 2,269 | 2,242 | 2,250 | -5 | -0.2% | 42,600 |
2023/04/06 | 2,218 | 2,260 | 2,218 | 2,255 | +12 | +0.5% | 67,700 |
2023/04/05 | 2,253 | 2,271 | 2,235 | 2,243 | -34 | -1.5% | 65,700 |
2023/04/04 | 2,247 | 2,280 | 2,237 | 2,277 | +29 | +1.3% | 67,600 |
2023/04/03 | 2,259 | 2,267 | 2,233 | 2,248 | +3 | +0.1% | 59,100 |
2023/03/31 | 2,230 | 2,249 | 2,230 | 2,245 | +25 | +1.1% | 57,300 |
2023/03/30 | 2,226 | 2,238 | 2,212 | 2,220 | -28 | -1.2% | 60,200 |
2023/03/29 | 2,232 | 2,250 | 2,211 | 2,248 | +33 | +1.5% | 141,100 |
2023/03/28 | 2,224 | 2,224 | 2,201 | 2,215 | +14 | +0.6% | 58,300 |
2023/03/27 | 2,198 | 2,209 | 2,189 | 2,201 | +28 | +1.3% | 65,800 |
2023/03/24 | 2,152 | 2,180 | 2,141 | 2,173 | +20 | +0.9% | 67,300 |
2023/03/23 | 2,154 | 2,182 | 2,144 | 2,153 | -28 | -1.3% | 45,500 |
2023/03/22 | 2,143 | 2,187 | 2,129 | 2,181 | +88 | +4.2% | 103,200 |
2023/03/20 | 2,111 | 2,123 | 2,091 | 2,093 | -35 | -1.6% | 59,000 |
2023/03/17 | 2,150 | 2,169 | 2,125 | 2,128 | -13 | -0.6% | 74,300 |
2023/03/16 | 2,132 | 2,144 | 2,117 | 2,141 | -30 | -1.4% | 62,700 |
2023/03/15 | 2,174 | 2,183 | 2,154 | 2,171 | +18 | +0.8% | 43,000 |
551~
600
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 206,000円 | +3.1% | -6.5% | 2.33% | 9.56倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 274,000円 | +21.7% | +999.9% | 0.00% | 12.62倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 318,500円 | +5.1% | -7.0% | 2.51% | 20.91倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 154,600円 | -2.4% | -52.3% | 3.69% | 18.50倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 238,900円 | +4.1% | -3.1% | 2.43% | 20.75倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム